HEIDI RINDERER: Open Payments
NPI 1245221985 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,310 in 119 payments from 19 companies in 2025. Trend: 2023 $1,624 · 2024 $1,729 · 2025 $2,310
Food & beverage: $2,131Education: $179
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 38 | $665 |
| ABBVIE INC. | 22 | $380 |
| Galderma Laboratories, L.P. | 7 | $244 |
| Novartis Pharmaceuticals Corporation | 6 | $131 |
| Organon LLC | 11 | $131 |
| Amgen Inc. | 5 | $113 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $102 |
| Regeneron Healthcare Solutions, Inc. | 4 | $79 |
| UCB, Inc. | 3 | $72 |
| PFIZER INC. | 3 | $69 |
Products named: TREMFYA, SKYRIZI, NEMLUVIO, Otezla, DUPIXENT, ILUMYA, RINVOQ, COSENTYX.
Industry payments across TN — which companies pay providers there.
